News

Attendence and Presentations at the 47th Annual JSCPT Conference ( in Fukui Prefecture )

This year at the 47th  Annual Scientific Meeting of the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT), located in Fukui Prefecture, some of our staff will be presenting our reseach in both general and poster presentations. For more details, please see the below: November 27th ( Friday) 1) 【Poster Presentation】1-P04-5 日本人健康成人対象試験における適切な総ビリルビン値の基準範囲の考察 Appropriate Upper Reference Limits for Total Bilirubin in Clinical Trials Involving Healthy Japanese Adults ( by SOUSEIKAI Fukuoka Mirai Hospital’s Dr. Tatsuya Yoshihara...

Three Approaches to Accessing the Japanese Market

An informative article in ASCPT’s Clinical and Translational Science from NOVARTIS was recently published, analyzing three approaches to accessing the Japanese market: the Japanese Phase I waiver, the first-in-human study conducted in Japan, and multifunctional Japanese Phase I studies. “Reimagining Early-Phase Clinical Development in Japan: From Regulatory Obligation to Global Acceleration” Further analysis of cycle times emphasizes Japan’s globally competitive timelines, as “a key location for first-in-human and early phase trials.” For those interested in...

Next News